Erlotinib induces the human non–small‐cell lung cancer cells apoptosis via activating ROS‐dependent JNK pathways

Although erlotinib (ERL) has drawn more and more attention toward its anticancer properties effect, the underlying mechanisms of ERL's anticancer properties effect remain unclear yet. So, the aim of this research was to explore the underlying anticancer mechanisms of ERL and to explore whether...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Med
Huvudupphovsmän: Shan, Fenglian, Shao, Zewei, Jiang, Shenghua, Cheng, Zhaozhong
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2016
Ämnen:
Cancer Biology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5119972/
https://ncbi.nlm.nih.gov/pubmed/27726288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.881
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk